358 related articles for article (PubMed ID: 18184225)
1. Vigabatrin and epilepsy: further lessons in early childhood.
Parisi P; Bombardieri R; Curatolo P
Epilepsia; 2008 Jan; 49(1):177-8. PubMed ID: 18184225
[No Abstract] [Full Text] [Related]
2. Vigabatrin and epilepsy: lessons learned.
Wild JM; Ahn HS; Baulac M; Bursztyn J; Chiron C; Gandolfo E; Safran AB; Schiefer U; Perucca E
Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
[TBL] [Abstract][Full Text] [Related]
3. Visual field constriction on vigabatrin.
Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
[TBL] [Abstract][Full Text] [Related]
4. [Changes in visual field of a child treatment with vigabatrin for 2 years].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):313-4. PubMed ID: 14746187
[TBL] [Abstract][Full Text] [Related]
5. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
6. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy.
Conway M; Cubbidge RP; Hosking SL
Epilepsia; 2008 Jan; 49(1):108-16. PubMed ID: 18184224
[TBL] [Abstract][Full Text] [Related]
7. [Constriction of the visual field by vigabatrin].
Asensio Sánchez VM
An Med Interna; 2002 Dec; 19(12):655-6. PubMed ID: 12593042
[No Abstract] [Full Text] [Related]
8. Vigabatrin and visual field disorders.
Prescrire Int; 2002 Dec; 11(62):182. PubMed ID: 12472095
[No Abstract] [Full Text] [Related]
9. Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy.
Clayton LM; Duncan JS; Sisodiya SM; Acheson JF
Eye (Lond); 2010 Jan; 24(1):185-6. PubMed ID: 19373265
[No Abstract] [Full Text] [Related]
10. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
Schmidt T; Rüther K; Jokiel B; Pfeiffer S; Tiel-Wilck K; Schmitz B
J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
[TBL] [Abstract][Full Text] [Related]
11. [Visual field disturbances in epileptic patients treated with vigabatrin (sevril)].
Gross-Tsur V; Lahat E; Banin E; Shahar E; Shalev R
Harefuah; 2002 Mar; 141(3):247-9, 315. PubMed ID: 11944216
[TBL] [Abstract][Full Text] [Related]
12. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study.
Schmitz B; Schmidt T; Jokiel B; Pfeiffer S; Tiel-Wilck K; Rüther K
J Neurol; 2002 Apr; 249(4):469-75. PubMed ID: 11967655
[TBL] [Abstract][Full Text] [Related]
13. Vigabatrin-associated visual field loss.
Fecarotta C; Sergott RC
Int Ophthalmol Clin; 2012; 52(3):87-94, xii. PubMed ID: 22668542
[No Abstract] [Full Text] [Related]
14. Vigabatrin: an antiepileptic drug with major benefits but significant adverse effects.
Besag FM
Curr Drug Saf; 2010 Jul; 5(3):188-90. PubMed ID: 20624131
[No Abstract] [Full Text] [Related]
15. Visual field defects associated with vigabratin monotherapy in children.
Luchetti A; Amadi A; Gobbi G
J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):566. PubMed ID: 11183043
[No Abstract] [Full Text] [Related]
16. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
17. Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin.
Werth R; Schädler G
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3028-35. PubMed ID: 16799049
[TBL] [Abstract][Full Text] [Related]
18. Visual field defect associated with vigabatrin. Many more patients may be affected than were found in study.
Comaish IF; Gorman C; Galloway NR
BMJ; 2000 May; 320(7246):1403; author reply 1404. PubMed ID: 10858054
[No Abstract] [Full Text] [Related]
19. Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin.
Sorri I
Acta Ophthalmol Scand; 2002 Jun; 80(3):343-4. PubMed ID: 12059879
[No Abstract] [Full Text] [Related]
20. [Vigabatrin and visual fields defects].
Jensen K
Ugeskr Laeger; 2001 Jan; 163(2):184. PubMed ID: 11379251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
